SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
-3.6%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$614M
AUM Growth
-$3.99M
(-0.65%)
Cap. Flow
+$47.9M
Cap. Flow
% of AUM
7.81%
Top 10 Holdings %
Top 10 Hldgs %
28.66%
Holding
127
New
28
Increased
30
Reduced
32
Closed
11
Top Buys
| 1 |
Skye Bioscience
SKYE
|
$10.4M |
| 2 |
ASML
ASML
|
$10.1M |
| 3 |
Apple
AAPL
|
$9.27M |
| 4 |
Amazon
AMZN
|
$9.08M |
| 5 |
Salesforce
CRM
|
$8.64M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$17.9M |
| 2 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$9.57M |
| 3 |
Camtek
CAMT
|
$9.14M |
| 4 |
Nova
NVMI
|
$6.23M |
| 5 |
SentinelOne
S
|
$5.62M |
Sector Composition
| 1 | Healthcare | 71.02% |
| 2 | Technology | 20.47% |
| 3 | Communication Services | 3.65% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Utilities | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Outlook Therapeutics
OTLK
$39.5M
| $4.22M | 0.58% |
571,428
-1
| -0% | -$7 |
|
52
WIX.com
WIX
$8.05B
| $4M | 0.55% |
25,177
-27,700
| -52% | -$4.41M |
|
53
Lam Research
LRCX
$124B
| $3.94M | 0.54% |
+37,000
| New | +$3.94M |
|
54
Savara
SVRA
$591M
| $3.88M | 0.53% |
+962,687
| New | +$3.88M |
|
55
GSK
GSK
$79.3B
| $3.85M | 0.53% |
100,000
| – | – |
|
56
Qualcomm
QCOM
$170B
| $3.75M | 0.51% |
18,825
+3,825
| +26% | +$762K |
|
57
Eledon Pharmaceuticals
ELDN
$155M
| $3.42M | 0.47% |
+1,297,021
| New | +$3.42M |
|
58
Akero Therapeutics
AKRO
$3.65B
| $3.32M | 0.45% |
141,620
-18,825
| -12% | -$442K |
|
|
SHLT
59
DELISTED
SHL Telemedicine Ltd American Depositary Shares
SHLT
| $3.22M | 0.44% |
632,456
| – | – |
|
60
Applied Therapeutics
APLT
$73.7M
| $3.15M | 0.43% |
674,268
+55,239
| +9% | +$258K |
|
61
Intellia Therapeutics
NTLA
$1.26B
| $3.12M | 0.43% |
+139,419
| New | +$3.12M |
|
62
Broadcom
AVGO
$1.42T
| $3.11M | 0.42% |
193,600
+183,590
| +1,834% | +$2.95M |
|
63
Analog Devices
ADI
$120B
| $2.97M | 0.4% |
+13,000
| New | +$2.97M |
|
64
PTC Therapeutics
PTCT
$4.41B
| $2.88M | 0.39% |
+94,318
| New | +$2.88M |
|
65
VistaGen Therapeutics
VTGN
$113M
| $2.81M | 0.38% |
808,550
| – | – |
|
66
Pliant Therapeutics
PLRX
$105M
| $2.78M | 0.38% |
258,554
| – | – |
|
67
Alector
ALEC
$282M
| $2.77M | 0.38% |
610,000
+50,000
| +9% | +$227K |
|
68
Enlight Renewable Energy
ENLT
$3.35B
| $2.74M | 0.37% |
169,280
| – | – |
|
69
ProMIS Neurosciences
PMN
$23.7M
| $2.72M | 0.37% |
1,814,213
-19,834
| -1% | -$29.8K |
|
70
KLA
KLAC
$111B
| $2.72M | 0.37% |
+3,300
| New | +$2.72M |
|
|
SWTX
71
DELISTED
SpringWorks Therapeutics
SWTX
| $2.65M | 0.36% |
70,269
| – | – |
|
72
Disc Medicine
IRON
$2.14B
| $2.62M | 0.36% |
58,044
+9,158
| +19% | +$413K |
|
|
CRGX
73
DELISTED
CARGO Therapeutics
CRGX
| $2.55M | 0.35% |
155,506
+80,506
| +107% | +$1.32M |
|
74
Pfizer
PFE
$141B
| $2.52M | 0.34% |
90,000
| – | – |
|
75
NVIDIA
NVDA
$4.15T
| $2.47M | 0.34% |
+20,000
| New | +$2.47M |
|